CsA治疗切脾治疗后复发难治性ITP临床分析  

Clinical analysis of Cs A in the treatment of relapsed refractory ITP after splenectomy

作　　者：林海清[1] 孙雄飞[1] 吴铭[1] 张新友[1] 姜容[1] 

机构地区：[1]深圳市人民医院血液科,518000

出　　处：《中国实用医药》2015年第16期31-33,共3页China Practical Medicine

摘　　要：目的评价环孢素A(Cs A)治疗切脾后复发难治性特发性血小板减少性紫癜(RITP)的疗效。方法对3例Cs A治疗切脾术后复发难治性ITP患者的临床资料进行回顾性分析。结果 Cs A治疗后,3例切脾后复发难治性ITP患者血小板均恢复至正常水平,且无明显副作用。结论环孢素A可以作为脾切除后复发难治性ITP安全、有效的治疗手段之一。Objective To evaluate curative effect of cyclosporin A （CsA） in the treatment of relapsed refractory idiopathic thrombocytopenic purpura （RITP） after splenectomy. Methods A retrospective analysis was made on the clinical data of 3 patients with relapsed refractory ITP after splenectomy treated by CsA. Results After CsA treatment, all the 3 cases with relapsed refractory ITP after splenectomy had recovered blood platelet as normal level, without obvious adverse reactions. Conclusion Cyclosporin A can be applied as one of the safe and effective Methods in treating relapsed refractory ITP after splenectomy.

关 键 词：环孢素A 复发难治性特发性血小板减少性紫癜 脾切除后 

分 类 号：R554.6[医药卫生—血液循环系统疾病]